Issues
Current Issue
Special Issues
Viewpoints
Editor’s Corner
Advanced Practice Voices
From Our Readers
You Make the Call: Readers’ Response
Guest Commentary
Letters to the Editor
A Day in the Life
Notes From the Hill
The Break Room
Education
You Make the Call
Hematologica Obscura
How I Teach
How I Treat In Brief
Demystifying the Lab
Practice Update
Spotlight
Feature Articles
Pulling Back the Curtain
Blood Beyond Borders
pASHions
Drawing First Blood
HemOnc Link
Interviews
News
Online Exclusives
Latest & Greatest
From the
Blood
Journals
Written in
Blood
Blood Advances
in a Different Vein
Literature Scan
ASH Directions
The Society Pages
Topic Compilations
COVID-19 News
Acute Leukemias
Chronic Leukemias
MDS & Myeloproliferative Neoplasms
Multiple Myeloma & Plasma Cell Disorders
Lymphomas & Lymphoid Neoplasia
Bleeding Disorders
Clotting Disorders
Red Blood Cell & Iron Disorders
On Location
ASH Annual Meeting
ASH Meeting on Hematologic Malignancies
ASH Meeting on Lymphoma Biology
Other Meetings
Multimedia
Sound Bites
Meeting Coverage
Search
ASH Home
About ASH Clinical News
Authors
Advertising
Subscribe
Contact Us
eNewsletters
Cookie Settings
LOG IN
Welcome! Log into your account
Forgot your password?
Recover your password
ASH Clinical News
Issues
All
Current Issue
Special Issues
April 2021 Volume 7 Issue 5
March 2021 Special Edition
March 2021 Volume 7 Issue 4
February 2021 Volume 7 Issue 3
Viewpoints
Editor’s Corner
Advanced Practice Voices
From Our Readers
You Make the Call: Readers’ Response
Guest Commentary
Letters to the Editor
A Day in the Life
Notes From the Hill
The Break Room
Education
You Make the Call
Hematologica Obscura
How I Teach
How I Treat In Brief
Demystifying the Lab
Practice Update
Spotlight
Feature Articles
Pulling Back the Curtain
Blood Beyond Borders
pASHions
Drawing First Blood
HemOnc Link
Interviews
News
Online Exclusives
Latest & Greatest
From the
Blood
Journals
Written in
Blood
Blood Advances
in a Different Vein
Literature Scan
ASH Directions
The Society Pages
Topic Compilations
COVID-19 News
Acute Leukemias
Chronic Leukemias
MDS & Myeloproliferative Neoplasms
Multiple Myeloma & Plasma Cell Disorders
Lymphomas & Lymphoid Neoplasia
Bleeding Disorders
Clotting Disorders
Red Blood Cell & Iron Disorders
On Location
ASH Annual Meeting
ASH Meeting on Hematologic Malignancies
ASH Meeting on Lymphoma Biology
Other Meetings
Multimedia
Sound Bites
Meeting Coverage
Generic selectors
Exact matches only
Exact matches only
Search in title
Search in title
Search in content
Search in content
Search in excerpt
Search in posts
Search in posts
Search in pages
Search in pages
Home
Issue Archive
Issue Archive
October 2014
Thursday, September 22, 2016
March 2015
Sunday, August 21, 2016
January 2015
Friday, August 5, 2016
April 2015
Tuesday, April 5, 2016
February 2015
Saturday, June 20, 2015
May 2015
Monday, March 9, 2015
December 2014
Tuesday, December 30, 2014
Advertisement
Current Issue
April 2021 Volume 7 Issue 5
Thursday, April 1, 2021
This issue examines long-haul COVID-19, central nervous system relapse in non-Hodgkin lymphoma, and more.
Block title
European Commission Approves Selinexor Plus Dexamethasone for Relapsed/Refractory Myeloma
Sunday, April 11, 2021
FDA Approves Isatuximab-irfc Combination for Relapsed/Refractory Myeloma
Sunday, April 11, 2021
Countries Restrict AstraZeneca Vaccine for Younger Adults
Sunday, April 11, 2021
Investigation Finds Hemophilia Gene Therapy Likely Did Not Cause Hepatocellular Carcinoma
Sunday, April 11, 2021
Daunorubicin and Cytarabine Combination Approved for Pediatric Secondary AML
Sunday, April 11, 2021
